Skip to content 
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. more
| Time Frame | BAX | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -6.87% | 0.72% | -1.31% |
| 1-Month Return | 7.02% | 1.27% | 0.78% |
| 3-Month Return | 14.27% | 3.13% | 3.46% |
| 6-Month Return | -12.16% | 15.81% | 6.19% |
| 1-Year Return | -33.53% | 8.89% | 11.68% |
| 3-Year Return | -49.04% | 20.79% | 71.21% |
| 5-Year Return | -73.69% | 35.89% | 74.81% |
| 10-Year Return | -45.52% | 138.44% | 256.59% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 12.78B | 14.51B | 10.36B | 10.64B | 11.24B | [{"date":"2021-12-31","value":88.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":71.42,"profit":true},{"date":"2024-12-31","value":73.32,"profit":true},{"date":"2025-12-31","value":77.51,"profit":true}] |
| Cost of Revenue | 7.43B | 6.51B | 6.21B | 6.65B | 7.87B | [{"date":"2021-12-31","value":94.42,"profit":true},{"date":"2022-12-31","value":82.75,"profit":true},{"date":"2023-12-31","value":78.96,"profit":true},{"date":"2024-12-31","value":84.58,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 4.72B | 3.55B | 4.15B | 3.98B | 3.38B | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":75.19,"profit":true},{"date":"2023-12-31","value":87.92,"profit":true},{"date":"2024-12-31","value":84.41,"profit":true},{"date":"2025-12-31","value":71.59,"profit":true}] |
| Gross Margin | 36.92% | 24.47% | 40.06% | 37.46% | 30.05% | [{"date":"2021-12-31","value":92.17,"profit":true},{"date":"2022-12-31","value":61.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.51,"profit":true},{"date":"2025-12-31","value":75.02,"profit":true}] |
| Operating Expenses | 3.37B | 6.39B | 3.44B | 3.97B | 132.00M | [{"date":"2021-12-31","value":52.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.85,"profit":true},{"date":"2024-12-31","value":62.09,"profit":true},{"date":"2025-12-31","value":2.06,"profit":true}] |
| Operating Income | 1.35B | (2.85B) | 707.00M | 14.00M | (6.00M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-210.74,"profit":false},{"date":"2023-12-31","value":52.37,"profit":true},{"date":"2024-12-31","value":1.04,"profit":true},{"date":"2025-12-31","value":-0.44,"profit":false}] |
| Total Non-Operating Income/Expense | (426.00M) | (798.00M) | (907.00M) | (644.00M) | (258.00M) | [{"date":"2021-12-31","value":-42600000000,"profit":false},{"date":"2022-12-31","value":-79800000000,"profit":false},{"date":"2023-12-31","value":-90700000000,"profit":false},{"date":"2024-12-31","value":-64400000000,"profit":false},{"date":"2025-12-31","value":-25800000000,"profit":false}] |
| Pre-Tax Income | 1.12B | (3.25B) | 242.00M | (289.00M) | (26.00M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-291.04,"profit":false},{"date":"2023-12-31","value":21.68,"profit":true},{"date":"2024-12-31","value":-25.9,"profit":false},{"date":"2025-12-31","value":-2.33,"profit":false}] |
| Income Taxes | 83.00M | (135.00M) | 61.00M | 37.00M | 128.00M | [{"date":"2021-12-31","value":64.84,"profit":true},{"date":"2022-12-31","value":-105.47,"profit":false},{"date":"2023-12-31","value":47.66,"profit":true},{"date":"2024-12-31","value":28.91,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income After Taxes | 1.03B | (3.11B) | 181.00M | (326.00M) | (154.00M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-301.36,"profit":false},{"date":"2023-12-31","value":17.52,"profit":true},{"date":"2024-12-31","value":-31.56,"profit":false},{"date":"2025-12-31","value":-14.91,"profit":false}] |
| Income From Continuous Operations | 1.29B | (2.42B) | (69.00M) | (326.00M) | (900.00M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-186.95,"profit":false},{"date":"2023-12-31","value":-5.33,"profit":false},{"date":"2024-12-31","value":-25.17,"profit":false},{"date":"2025-12-31","value":-69.5,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 1.28B | (2.43B) | 2.66B | (649.00M) | 1.14B | [{"date":"2021-12-31","value":48.34,"profit":true},{"date":"2022-12-31","value":-91.6,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-24.44,"profit":false},{"date":"2025-12-31","value":42.77,"profit":true}] |
| EPS (Diluted) | 3.62 | 3.50 | 2.70 | 2.40 | 2.27 | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.69,"profit":true},{"date":"2023-12-31","value":74.59,"profit":true},{"date":"2024-12-31","value":66.3,"profit":true},{"date":"2025-12-31","value":62.71,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| BAX | |
|---|---|
| Cash Ratio | 0.66 |
| Current Ratio | 2.31 |
| Quick Ratio | 1.56 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BAX | |
|---|---|
| ROA (LTM) | 2.83% |
| ROE (LTM) | -13.71% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| BAX | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.70 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.31 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BAX | |
|---|---|
| Trailing PE | NM |
| Forward PE | 8.44 |
| P/S (TTM) | 0.95 |
| P/B | 1.66 |
| Price/FCF | 24 |
| EV/R | 1.60 |
| EV/Ebitda | 23.49 |
| PEG | 36.68 |
Baxter International Inc (BAX) share price today is $21.87
Yes, Indians can buy shares of Baxter International Inc (BAX) on Vested. To buy
Yes, you can purchase fractional shares of Baxter International Inc (BAX) via the Vested app. You can start investing in Baxter International Inc (BAX) with a minimum investment of $1.
You can invest in shares of Baxter International Inc (BAX) via Vested in three simple steps:
The 52-week high price of Baxter International Inc (BAX) is $37.25. The 52-week low price of Baxter International Inc (BAX) is $17.39.
The price-to-earnings (P/E) ratio of Baxter International Inc (BAX) is
The price-to-book (P/B) ratio of Baxter International Inc (BAX) is 1.66
The dividend yield of Baxter International Inc (BAX) is 2.78%
The market capitalization of Baxter International Inc (BAX) is $10.67B
The stock symbol (or ticker) of Baxter International Inc is BAX
Consider the share price of Baxter International Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Baxter International Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Baxter International Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Baxter International Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Baxter International Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Baxter International Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
